Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1171)	12/3/1998 12:33:00 AM
From: Anthony Wong	Read Replies (2) \| Respond to of 1722

Biotechs rise during conference By Stephanie O'Brien, CBS MarketWatch Last Update: 5:18 PM ET Dec 2, 1998 NewsWatch NEW YORK (CBS.MW) -- Shares of biotechnology companies were on the rise, as the second day of the BancBoston Robertson Stephens 15th Annual Medical Conference drew to a close. Movers in the Amex Biotech Index include Cor Therapeutics (CORR), which rose 1 9/16 to close at 13 1/2; Genzyme Corp.(GENZ), which rose 4 1/8 to close at 45 5/8 and Gilead Sciences (GILD), which climbed 1 3/4, closing at 33 5/8. By the time the three-day conference closes, investors will have seen some 200 presentations by companies specializing in pharmaceuticals, home healthcare, life sciences and other healthcare-related businesses. The conference ends Thursday afternoon. Companies scheduled to give presentations in New York on Thursday include Healthsouth Corp.(HRC), Alza Corp.(AZA), IMS Health Inc.(RX), Immunex (IMNX), Genzyme (GENZ) and Centocor (CNTO).